Power3 Medical Products, Inc. Files for Patent on Diagnosis of Early Stage PD
 

Power3 Medical Products, Inc. Files for Patent on Diagnosis of Early Stage Parkinsons Disease

Mon. August 03, 2009; Posted: 07:00 AM
http://www.tradingmarkets.com/.site/...0News/2455943/

Woodlands, TX, Aug 03, 2009 (WORLD STOCK WIRE via COMTEX) -- TBIO | Quote | Chart | News | PowerRating -- Power3 Medical Products, Inc. (OTCBB:PWRM), (www.power3medical.com), announced today that the Company has filed a patent for Diagnosis of Early Stage Parkinsons Disease: Abnormal: Blood Serum Concentrations of a Select Group of Protein Biomarkers.

Power3 Medical Products, Inc. filed a provisional patent on the diagnosis
of early stage Parkinsons disease: abnormal blood serum concentrations of a select group of protein biomarkers. This not only announces to the industry the progress of the Nuro-Pro-PD test for Parkinsons, in validation, utility, but that the importance of the Power3 protein biomarkers are statistically valid for use as a diagnostic test.

This work was done in conjunction with Transgenomic, Inc. license/collaboration agreement. The patent provides coverage of biomarkers and the computation/statistical methods used to discriminate the disease vs. the normal controls.

"Power3 Medical is continuing the portfolio of it intellectual property in Neurodegenerative diagnosis. We recently filed a patent on the ability of Power3's Nuro-Pro-PD test, using a series of abnormal blood serum biomarkers, to distinguish the early onset of Parkinson's disease", stated Dr. Ira L. Goldknopf, President and Chief Scientific Officer of Power3. "This patent is a break through declaration of new discoveries in this field."